Phase 4 Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between the ages of 19 and under 85
- People who are willing to give their consent to take part and are able to attend follow-up appointments during the study
- People who have both atrial fibrillation (an irregular heartbeat) and heart failure, and who have either had a catheter ablation procedure for atrial fibrillation within the last three months, or have one scheduled
Who may not be able to join:
- People who are under 19 or 85 years of age or older
- People who have taken part in another clinical trial within the last three months
- People who are expected to live less than one year
- Women who are pregnant or breastfeeding
- People who are currently being treated with a type of medication called an SGLT-2 inhibitor
- People who have had three or more urinary or genital infections in the past year
- People with poorly controlled high blood pressure (confirm with trial site for specific measurements)
- People with very low blood pressure (confirm with trial site for specific measurements)
- People who have had a serious heart or cardiovascular event within the last 12 weeks
- People with severe heart valve disease or who have artificial heart valves
- People with significantly reduced kidney function (confirm with trial site for specific measurements)
- People with a medically confirmed liver condition affecting liver function
- People with thyroid problems that are not well controlled
- People who currently have cancer or are receiving cancer treatment, or who have had cancer within the last five years — though some people with certain low-risk cancers that were successfully treated may still be eligible (confirm with trial site)
- People who have been taking high-dose steroid tablets (such as prednisolone at 10mg per day or more) continuously within the last month
- People who have had an allergic reaction to any ingredient in the study drug, or who have a history of such a reaction
- People with type 1 diabetes or a condition called diabetic ketoacidosis
- People with a history of alcohol or substance misuse
- Women who could become pregnant but are unwilling to use adequate contraception for the duration of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in the recurrence rate of atrial fibrillation (AF) between the experimental group (enavogliflozin group) and the control group (placebo group) from 3 months to 1 year after catheter ablation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.